Andrew Reardon

Andrew Reardon

Director/Board Member at VERNALIS

Net worth: 13 M $ as of 29/06/2026

52 year
Health Technology
Consumer Services
Commercial Services

Profile

Andrew Thomas Reardon is currently Director at Ligand UK Ltd. since 2022.
Mr. Reardon is also Secretary & Chief Legal Officer at Ligand Pharmaceuticals, Inc. since 2022.
Formerly, Mr. Reardon was Senior Associate at Willkie Farr & Gallagher LLP, Principal at The United States Army (District of Columbia), and Vice President-Legal at Healthcare Royalty Management LLC.
Mr. Reardon completed graduate studies at The University of Iowa College of Law and undergraduate studies at State University of New York at Old Westbury.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/06/2026 41,514 ( 0.21% ) 13 M $ 29/06/2026

Andrew Reardon active positions

CompaniesPositionStart
LIGAND PHARMACEUTICALS INCORPORATED General Counsel 31/12/2021
VERNALIS Director/Board Member 31/10/2022

Former positions of Andrew Reardon

CompaniesPositionEnd
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Andrew Reardon's experience

Training of Andrew Reardon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

12

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Commercial Services

Consumer Services

Government

Finance

Consumer Services

  1. Stock Market
  2. Insiders
  3. Andrew Reardon